Various breast cancer phenotypes have been defined based on molecular pathology, including the myoepithelial basal-like carcinoma of the breast that is characterized as ER-negative and HER2-negative with increased expression of CK5 and p63 (Fadare and Tavassoli 2007; Yehiely et al. 2006). Here, ERBB2 is linked to breast cancer.